中国儿童保健杂志 ›› 2022, Vol. 30 ›› Issue (7): 737-740.DOI: 10.11852/zgetbjzz2021-0133

• 综述 • 上一篇    下一篇

神经母细胞瘤扩增序列基因缺陷研究进展

周妍杉, 谭书江   

  1. 重庆市涪陵中心医院儿科,重庆 408000
  • 收稿日期:2021-01-22 修回日期:2021-03-25 发布日期:2022-07-25 出版日期:2022-07-10
  • 通讯作者: 谭书江,E-mail:2586648988@qq.com
  • 作者简介:周妍杉(1992-),女,重庆人,主治医师,硕士研究生,主要研究小儿消化系统疾病。

Research advances in NBAS gene defect

ZHOU Yan-shan, TAN Shu-jiang   

  1. Department of Pediatrics, Chongqing Fuling Central Hospital, Chongqing 408000, China
  • Received:2021-01-22 Revised:2021-03-25 Online:2022-07-10 Published:2022-07-25
  • Contact: TAN Shu-jiang, E-mail:2586648988@qq.com

摘要: 神经母细胞瘤扩增序列基因(NBAS基因)缺陷可导致常染色体隐性遗传病,是一种罕见的基因缺陷。该基因缺陷可累及全身多个系统。临床主要表现有身材矮小、视神经萎缩、Pelger-Huët细胞畸形及与发热相关的肝功能衰竭。本文主要从NBAS基因缺陷可能的发病机制、基因缺陷与表型的关系、临床表现、治疗、诊断和预后作一综述。

关键词: NBAS基因, NMD通路, 肝衰竭

Abstract: Neuroblastoma amplified sequence(NBAS) gene deficiency can lead to autosomal recessive hereditary disease, which is a rare genetic defect. Besides, NBAS gene deficiency can affect multiple systems. The main clinical manifestations include short stature, optic atrophy, Pelger-Huet cell malformation and febrile related liver failure. This article mainly reviews the possible pathogenesis of NBAS gene defects, the relationship between gene defects and phenotypes, clinical manifestations, treatment, diagnosis, and prognosis of NBAS gene defects.

Key words: neuroblastoma amplified sequence gene, NMD pathway, liver failure

中图分类号: